James R. Baker, Jr., MD
Chief Executive Officer and Chief Medical Officer
James R. Baker, Jr., MD, is the CEO and chief medical officer of FARE. For 20 years, Dr. Baker was the chief of the Division of Allergy and Clinical Immunology at the University of Michigan, where he helped start the Food Allergy Research Center. He has also served as the Ruth Dow Doan Professor since 2003 and he retains his professorship and serves in an emeritus capacity at the University. Dr. Baker has authored more than 350 peer-reviewed scientific articles and also has more than 30 years of experience in basic biologic research, concentrating in immunology and host defense both at the University of Michigan and in industry at Merck, where he served as a senior vice president and the global head of vaccines. His long-standing research in immunology involves the basis of several autoimmune diseases, and he has become an internationally recognized expert in nanotechnology, nanomolecular materials in biomedical applications and the emerging field of nanomedicine.
Senior Vice President and Chief Financial Officer
Sandeep previously served as Vice President for Finance and the Deputy Chief Financial Officer at Pharmaceutical Research and Manufacturers of America (PhRMA). He previously worked for healthcare industry brands GE Healthcare and Novartis. Sandeep is a graduate of Panjab University who earned both an MBA and completed the Executive Development Program at the Wharton School of Business, University of Pennsylvania. He is also a CPA, CMA and holds a Financial Planning Certificate from Georgetown University, Washington, DC.
Mary Jane Marchisotto
Senior Vice President of Research and International Operations
Before joining FARE, Mary Jane spent more than 30 years in the financial services industry, including at JP Morgan Chase, Citibank and Morgan Stanley, concentrating on financial management issues and on the development of internal best practices. Mary Jane was previously the Executive Director of FAI. She serves as co-chair of the Patient Organization Committee of the European Academy of Allergy and Clinical Immunology, chair of the International Food and Anaphylaxis Alliance, is a member of the Adverse Reactions Committee of The American Academy of Allergy Asthma and Immunology and is serving on the Sharing Clinical Trial Data Action Collaborative of the National Academy of Medicine. She is a graduate of Wells College and holds an MBA in Finance from Columbia Business School.
Senior Vice President of Education and Advocacy
A food allergy dad, Scott is an experienced advocate and leader. He has held strategic leadership roles at various companies including Dendreon, The Leukemia & Lymphoma Society and most recently, Synageva Biopharma. He is also Chair of the Board of Directors for the Patient Empowerment Network. Prior to FARE, Scott was the Vice-President of Global Patient Advocacy at Synageva Biopharma, a biotechnology company based in Lexington, MA, dedicated to discovering, developing and delivering therapies for patients with rare diseases. He is a graduate of Middlebury College and holds an MBA in Entrepreneurship & Strategy from the University of Chicago, Booth School of Business.
Lois A. Witkop
Chief Advancement Officer
Lois is an accomplished marketing communications professional with more than 20 years of experience in both the nonprofit and private sectors. Prior to FARE, she spent 10 years at the American Diabetes Association (ADA), including seven years in the position of Senior Vice President of Marketing Communications. Prior to the ADA, Ms. Witkop held management-level marketing positions with the US Pharmacopeia, the American Red Cross and The Dial Corporation. She is a graduate of Boston College and holds an MBA from Arizona State University.